Omaxe Ltd Q1 FY27 Results: Consolidated Profit Rebounds, Standalone Operations Lag

Omaxe Ltd announced its Q1 FY27 results, reporting a consolidated net profit of ₹1.30 crore, a sharp turnaround from a net loss of ₹185.77 crore in the same period last year. Consolidated revenue stood at ₹406.17 crore.

Reader Takeaway: Consolidated profit rebound positive; standalone losses and SEBI litigation remain key concerns.

What just happened

Omaxe Limited's consolidated financial performance for the quarter ending June 30, 2026, shows a significant improvement, moving from a substantial net loss to a modest profit. Consolidated revenue for the quarter was ₹406.17 crore.

Why this matters

The turnaround at the consolidated level indicates potential operational efficiencies or improved market conditions benefiting the group. However, the continued net loss of ₹31.88 crore at the standalone level for the same period highlights ongoing challenges within the parent entity's direct operations, though this loss is narrower than the ₹35.83 crore loss reported in Q1 FY26.

The backstory

In the previous fiscal year's first quarter (Q1 FY26), Omaxe Ltd faced a consolidated net loss of ₹185.77 crore, underscoring a difficult operational period. The current results mark a shift from that challenging phase at the group level.

What changes now

This result suggests improved group-level performance, which could boost investor confidence. However, the persistent standalone losses mean the company needs to address core operational profitability. The ongoing legal battle with SEBI adds a layer of uncertainty.

Risks to watch

Investors should closely monitor the standalone business performance for signs of sustained profitability. Additionally, the outcome of the appeal before the Securities Appellate Tribunal (SAT) concerning the SEBI order is a significant watch point, despite the management's assessment that it will not materially impact financials.

Peer comparison

(No specific peer comparison data available in the filing.)

Context metrics (time-bound)

• Consolidated Revenue (Q1 FY27): ₹406.17 crore
• Consolidated Net Profit (Q1 FY27): ₹1.30 crore
• Standalone Revenue (Q1 FY27): ₹75.82 crore
• Standalone Net Loss (Q1 FY27): ₹(31.88) crore
• Previous Year Consolidated Net Loss (Q1 FY26): ₹(185.77) crore
• Previous Year Standalone Net Loss (Q1 FY26): ₹(35.83) crore

What to track next

The upcoming quarters will be crucial to see if Omaxe can sustain consolidated profitability and improve its standalone operational results. The final verdict from the SAT on the SEBI order will also be a key development to watch.